A stimulating way to improve T cell responses to poxvirus-vectored vaccines.
Level V
Where this comes from
- Record sourced from PubMed, PMID 21183782.
- Also identified by DOI 10.1172/JCI45726 and PMC identifier 3007171.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Vaccines remain one of the most cost-effective public health measures. Despite ongoing efforts, protective vaccines against cancer and many infectious diseases, including malaria, tuberculosis, and HIV/AIDS, are still not in hand. Most investigators believe that to succeed against these difficult targets, vaccines that generate potent T cell responses are needed. In this issue of the JCI, Salek-Ardakani et al. show how the relative virulence of a virus/vaccine vector affects the memory CD8+ T cells generated and how the response may be enhanced. The work has important implications for the development of future vaccines that aim to trigger CD8+ T cell responses.
Medical subject headings
- CD8-Positive T-Lymphocytes
- Genetic Vectors
- Poxviridae
- Vaccines, Synthetic